2023-04-01 11095242 2024-03-31 11095242 2023-04-01 2024-03-31 11095242 2023-03-31 11095242 2022-04-01 2023-03-31 11095242 uk-core:WithinOneYear 2023-03-31 11095242 uk-core:WithinOneYear 2024-03-31 11095242 uk-core:AfterOneYear 2023-03-31 11095242 uk-core:AfterOneYear 2024-03-31 11095242 uk-core:ShareCapital 2024-03-31 11095242 uk-core:ShareCapital 2023-03-31 11095242 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 11095242 uk-core:RetainedEarningsAccumulatedLosses 2023-03-31 11095242 uk-bus:Director1 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure 11095242 uk-bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 11095242 uk-bus:FRS102 2023-04-01 2024-03-31 11095242 uk-bus:FilletedAccounts 2023-04-01 2024-03-31 11095242 uk-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31
MPHARM HOLDINGS LIMITED
Registered Number:11095242
For the year ended 31 March 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 31 March 2024
MPHARM HOLDINGS LIMITED
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
11095242
As at 31 March 2024
MPHARM HOLDINGS LIMITED
Statement of Financial Position
£
£
31/3/2023
31/3/2024
Fixed assets
Intangible assets
395,880
156,000
Property, plant and equipment
16,551
6,463
412,431
162,463
Current assets
Inventories
14,925
56,520
Trade and other receivables
115,526
154,191
59,242
Cash and cash equivalents
63,837
274,548
189,693
Trade and other payables: amounts falling due within one
year
(126,329)
(219,055)
63,364
55,493
Net current assets
Total assets less current liabilities
467,924
225,827
Trade and other payables: amounts falling due after more
than one year
(138,052)
(365,600)
(3,145)
(1,228)
Provisions for liabilities
99,179
Net assets
86,547
Capital and reserves
Called up share capital
100
100
Retained earnings
99,079
86,447
99,179
86,547
Shareholders' funds
For the year ended 31 March 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
1 of 3
4
Registered Number :
11095242
For the year ended 31 March 2024
MPHARM HOLDINGS LIMITED
Statement of Financial Position Continued
Mr Zakar Hayat Director
These financial statements were approved and authorised for issue by the Board on 04 December 2024 and were signed by:
The notes form part of these financial statements
2 of 3
5
For the year ended 31 March 2024
MPHARM HOLDINGS LIMITED
Notes to the Financial Statements
Statutory Information
MPHARM HOLDINGS LIMITED is a private limited company, limited by shares, domiciled in England and Wales,
registration number 11095242.
Principal place of business:
36 Abel Street
Burnley
Lancashire
BB10 1QR
Registered address:
14 Haworth Grove
Bradford
West Yorkshire
BD9 5PE
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
1. Average number of persons employed
During the year the average number of employees was 11 (2023 : 4)
3 of 3